Page 17 - Iontech News Today

Missouri providers will be offering bivalent COVID-19 boosters as soon as Friday following the CDCs approval of their use.

NEW YORK CITY (dpa-AFX) - The US Food and Drug Administration has authorized the COVID-19 booster dose of both Moderna (MRNA) and Pfizer-BioNTech that target the currently dominant BA.4 and BA.5

The adapted vaccines were made by Pfizer/BioNTech and Moderna

CHMP recommendation based on safety, tolerability, and immunogenicity data from a Phase 2/3 trial of the Omicron BA.1-adapted bivalent vaccine The Omicron BA.1-adapted bivalent COVID-19 vaccine

Reading and math test scores among elementary school children dropped to historically low levels during the coronavirus pandemic.

A CDC advisory panel endorsed omicron-specific COVID vaccine boosters for all US adults, a day after the FDA authorized the Moderna and Pfizer shots.

NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration granted Emergency Use Authorization of a 30-microgram booster dose of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original [15

Authorization based on clinical, pre-clinical and manufacturing data for Omicron-adapted bivalent vaccines Pfizer-BioNTech Omicron BA.4/BA.5 Bivalent Vaccine combines 15-g of mRNA encoding

Until now, Covid-19 vaccines have targeted the original coronavirus strain, even as wildly different mutants emerged. The new US boosters are combination, or “bivalent” shots.

Placer County officials said they recorded the countys first coronavirus-related death of a resident under the age of 18.